Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

Lisa Seekircher; Zoltán Bánki; Janine Kimpel; Annika Rössler; Helena Schäfer; Barbara Falkensammer; David Bante; Lukas Forer; Sebastian Schönherr; Teresa Harthaller; Magdalena Sacher; Cornelia Ower; Lena Tschiderer; Hanno Ulmer; Florian Krammer; Dorothee von Laer; Wegene Borena; Peter Willeit

doi:10.1101/2022.04.19.22273872

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

View ORCID ProfileLisa Seekircher, View ORCID ProfileZoltán Bánki, View ORCID ProfileJanine Kimpel, View ORCID ProfileAnnika Rössler, Helena Schäfer, Barbara Falkensammer, David Bante, Lukas Forer, Sebastian Schönherr, Teresa Harthaller, View ORCID ProfileMagdalena Sacher, View ORCID ProfileCornelia Ower, View ORCID ProfileLena Tschiderer, View ORCID ProfileHanno Ulmer, View ORCID ProfileFlorian Krammer, View ORCID ProfileDorothee von Laer, View ORCID ProfileWegene Borena, View ORCID ProfilePeter Willeit

doi: https://doi.org/10.1101/2022.04.19.22273872

Lisa Seekircher

1Clinical Epidemiology Team, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lisa Seekircher

Zoltán Bánki

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Zoltán Bánki

Janine Kimpel

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Janine Kimpel

Annika Rössler

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Annika Rössler

Helena Schäfer

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barbara Falkensammer

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Bante

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lukas Forer

3Institute of Genetic Epidemiology, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sebastian Schönherr

3Institute of Genetic Epidemiology, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Teresa Harthaller

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Magdalena Sacher

4Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Magdalena Sacher

Cornelia Ower

5Department of Surgery, University Hospital of Trauma Surgery, Medical University of Innsbruck, Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Cornelia Ower

Lena Tschiderer

1Clinical Epidemiology Team, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lena Tschiderer

Hanno Ulmer

6Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Hanno Ulmer

Florian Krammer

7Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

8Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Florian Krammer

Dorothee von Laer

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Dorothee von Laer

Wegene Borena

2Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Wegene Borena
For correspondence: wegene.borena@i-med.ac.at peter.willeit@i-med.ac.at

Peter Willeit

1Clinical Epidemiology Team, Medical University of Innsbruck, Austria

9Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Peter Willeit
For correspondence: wegene.borena@i-med.ac.at peter.willeit@i-med.ac.at

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplementary Material[supplements/273872_file02.pdf]

View the discussion thread.

PreviousNext

Posted April 21, 2022.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

Lisa Seekircher, Zoltán Bánki, Janine Kimpel, Annika Rössler, Helena Schäfer, Barbara Falkensammer, David Bante, Lukas Forer, Sebastian Schönherr, Teresa Harthaller, Magdalena Sacher, Cornelia Ower, Lena Tschiderer, Hanno Ulmer, Florian Krammer, Dorothee von Laer, Wegene Borena, Peter Willeit

medRxiv 2022.04.19.22273872; doi: https://doi.org/10.1101/2022.04.19.22273872

Share This Article: